Gut associated metabolites and their roles in Clostridioides difficile pathogenesis
The nosocomial pathogen Clostridioides difficile is a burden to the healthcare system. Gut microbiome disruption, most commonly by broad-spectrum antibiotic treatment, is well established to generate a state that is susceptible to CDI. A variety of metabolites produced by the host and/or gut microbi...
Saved in:
| Main Authors: | Andrea Martinez Aguirre, Joseph A. Sorg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2022.2094672 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-invasive treatment of Clostridioides difficile infection with a human-origin probiotic cocktail through gut microbiome-gut metabolome modulations
by: Bijay Gurung, et al.
Published: (2025-02-01) -
Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice
by: Sophie A. Millard, et al.
Published: (2025-07-01) -
Gut Microbiota Composition and Clostridioides Difficile Infection: The Potential Protective Role of Faecalibacterium Prausnitzii
by: Nadim Cassir, et al.
Published: (2024-12-01) -
Dietary iron attenuates Clostridioides difficile infection via modulation of intestinal immune response and gut microbiota
by: Xiao Li, et al.
Published: (2025-12-01) -
Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection
by: Shaodong Wei, et al.
Published: (2022-12-01)